Delivery Order SPE2DR25D1109-SPE2DR26FFK4N
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,459.68 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 18 mg tablets (100 count) on January 8, 2026, with completion expected by January 9, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor providing critical medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count) valued at $4,134.36 under a firm fixed price contract type. This delivery order, issued on December 17, 2025, with an ultimate completion date of December 18, 2025, represents a non-competitive set-aside award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,783.57 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count) with a completion deadline of September 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply framework. The contractor, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order valued at $1,025.87 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 mg tablets (100 count) with a completion date of January 8, 2026. This non-competitive delivery order was executed on January 7, 2026, under a firm fixed-price arrangement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $1,563.44 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 18 mg tablets (100-count bottles) with an ultimate completion date of January 8, 2026. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing...
- The Defense Logistics Agency awarded a delivery order valued at $1,690.77 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count bottles) on July 30, 2025, with completion scheduled for July 31, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order falls under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 54 mg tablets (100-count) with a ceiling value of $4,699.94. This competitively awarded, firm fixed-price delivery order was issued on December 15, 2025, with an ultimate completion date of December 16, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order valued at $1,343.58 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54mg tablets (100 count) on November 24, 2025, with completion scheduled for November 25, 2025. This non-set-aside competitive award reflects a firm fixed-price delivery order structure and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a $1,512.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Methylphenidate ER 54 mg on December 17, 2025, with completion scheduled for December 18, 2025. This non-competitive delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,474.45 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count packaging). This non-competitive, firm fixed-price delivery order was executed on August 19, 2025, with an ultimate completion date of August 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the company's existing federal...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFK4NDelivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,408.68 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100 count) with a completion date of January 12, 2026. This non-set-aside, competitively awarded contract was executed on January 9, 2026, with performance taking place at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor serving federal medical procurement needs, fulfilled this order under its parent company Cencora, Inc. This delivery order represents a task order executed under a larger Indefinite Delivery Contract vehicle with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 1/8/26 |